HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

4 hedge funds and large institutions have $377K invested in Hepion Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$278K +$278K +115 New
ARTA
2
A.R.T. Advisors
New York
$46K +$46K +19 New
VF
3
Virtu Financial
New York
$44K -$39.1K -16 -47%
UBS Group
4
UBS Group
Switzerland
$9K +$9K +4 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$44K -11 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
-$43K -10 Closed
Barclays
7
Barclays
United Kingdom
-$3K -1 Closed
Morgan Stanley
8
Morgan Stanley
New York
-$1K